Book a consultation

octoplant Use Cases by Industry: Automotive, Pharma, Food and Utilities

octoplant Pharma and Life Sciences Guide: Validated Change Control for Automation

octoplant pharma use: how backup, compare and audit trail support GMP change control for PLCs and HMIs, IQ/OQ for the tool, and where it gets hard.

Vladimir Romanov


octoplant pharma use rests on one idea: in a validated plant, a change to PLC or HMI code is a change to the validated state, and the plant must be able to show what changed, who changed it, why, and that it was approved and tested. Most pharma sites manage that with paper or electronic change requests that describe the change. What they often cannot show is that the code in the controller today is the code that was approved. This page explains how automation change management fits GMP change control, what validating the tool itself involves, and where it gets hard. It sits under octoplant use cases by industry in our independent AMDT overview.

What this page does not repeat. The audit trail requirements of FDA 21 CFR Part 11 and EU Annex 11, and how octoplant’s records map to them, are covered on audit trail and 21 CFR Part 11. The wider regulatory picture is on Compliance.

Where automation code escapes change control

The quality system is usually strong at the document level and weak at the device level. Code changes reach validated equipment through routes the change request never sees:

  • Online edits during a breakdown. A technician changes a timer or an interlock to recover a batch, intending to raise the change request in the morning.
  • Vendor service visits. An OEM engineer updates the firmware or logic on a skid during preventive maintenance and leaves a service report that says “software updated.”
  • Restores from the wrong file. After a hardware failure, someone loads the program from a network share that holds three versions with similar names.
  • Commissioning carry-over. Code changed during qualification runs is not the version that was frozen in the documentation.
Operators in full cleanroom suits working at microscopes along a long production hall
Gowning and procedures control what enters the room. They cannot show whether the code on the equipment is still the version that was qualified; only a compare against the device can.

Illustrative scenario. A CIP skid alarms on low return temperature. A night-shift technician lowers the alarm setpoint by two degrees in the PLC to finish the cycle. The batch completes. Three weeks later an auditor asks for evidence that the cleaning validation parameters are unchanged since qualification, and the plant discovers the edit only by comparing the running program against the qualified version. Every batch cleaned since is now part of an investigation.

AMDT frames the stake the same way on its pharma page: changes to automation configurations “can affect a validated production environment and trigger investigation, documentation, testing, or revalidation activities” (AMDT).

How octoplant pharma use maps to GMP change control

Validated change control loop with device-level evidence Upper row: the quality system's change control steps, from change request and impact assessment to approval, implementation, testing and closure. Lower row: the evidence octoplant can supply at each step, namely the approved version checked out, the edit made in the native tool, a compare of new against old attached to testing, check-in of the new approved version, and scheduled compares afterwards. A side branch shows that a scheduled compare finding a difference with no change record leads to a deviation for the quality system. Quality system steps (top) and device-level evidence a tool can supply (bottom) Change request and impact Approval to implement Implement the code change Test and verify against the risk Close and release Check out approved version Edit in native engineering tool Compare report new against old Check in new approved Scheduled compare against approved Difference, no record raise a deviation The tool supplies evidence. Impact assessment, testing and release decisions stay with the quality system.
Change control already exists on paper. What the tool adds is the device-level link: proof that the code approved is the code running, and a scheduled check that it stays that way.
Change control stepWhat the plant must be able to showWhat octoplant can contributeWhat stays with people and the QMS
BaselineThe qualified version of each programA stored, versioned approved copy per deviceDeclaring which version is the qualified one
ImplementationThat the change made matches the change approvedCheck-in and check-out with user, time and commentLinking the version to the change request number
VerificationExactly what changed, for the test scopeA Smart Compare report of new against oldDeciding what to test and signing it off
Ongoing controlNo unrecorded changes since releaseScheduled upload and compare, with alertsInvestigating each difference as a possible deviation
RecoveryThe validated program can be restoredRestore of the approved versionPost-restore verification before release to production

Validating the tool itself

A tool used to hold GxP evidence becomes a computerised system in its own right, and it needs to be qualified. AMDT lists IQ/OQ Services among its offerings: installation qualification (the software is installed as specified) and operational qualification (it works as specified in your environment). Performance qualification against your processes, the user requirements and the risk assessment remain the plant’s work. How a site categorises the tool under GAMP 5 is a decision for its validation lead, not the vendor.

Two history points matter for buyers. AUVESY sold a versiondog GxP Edition; whether octoplant has a direct equivalent is not confirmed in public sources. AMDT’s published editions are Core, Plus and Premium, with Premium described as the package for “medium and large or highly regulated environments” (octoplant pricing), as of October 2026. The per-edition feature split is not published, so ask which audit trail, approval and reporting features sit in which edition before you write the user requirements. Sites still on versiondog should read versiondog and AutoSave, because moving a validated system to a new platform is itself a validated change.

octoplant pharma case study and the frameworks AMDT cites

AMDT’s one named pharma story is Reliable OT Data at Humanwell Pharmaceutical. Yichang Humanwell makes anesthetic and other controlled products. As AMDT tells it, parameters had been set by hand and checked through several control steps, and documenting changes took considerable effort. Humanwell selected “the AMDT solution” in 2019 and first used it on a new freeze-dried emulsion line in 2020, for central storage of device programs, automatic backups and a record of changes. The story describes benefits, including “faster access to validated process configurations”, but not how the tool itself was validated or any figures. Note the dates: the selection predates octoplant, so the product in use may have been a predecessor. AMDT’s pharma page names FDA 21 CFR Part 11, cGMP (21 CFR Parts 210 and 211), EU GMP Annex 11, GAMP 5 and NIS2 as the frameworks it addresses (AMDT).

What changes for each team

Adopting the tool shifts work between groups, and the change control SOP should say so:

  • Quality assurance reviews compare reports instead of narrative descriptions of a change, which makes the impact assessment more precise and the test scope easier to defend.
  • Automation engineering works from a checked-out approved version rather than “the latest file on the share,” and records the change request number at check-in.
  • Maintenance restores from the approved version after a failure and hands the device back to QA for verification, instead of loading whatever file is closest.
  • Periodic review of each computerised system becomes faster, because a compare of running against qualified versions answers the first question an inspector asks.

Where it gets hard

  • Upgrading a validated tool. octoplant releases regularly (105 in August 2025, 107 in April 2026, per AMDT). Each upgrade on a validated installation is a change with its own assessment and testing, so many sites fall behind and lose device support for newer editors.
  • Two audit trails. The engineering software and the change management tool each keep a record. Decide which one is the record of truth for each kind of change, and write it into the SOP.
  • DCS and batch systems. API plants often run a DCS with its own configuration management. Check AMDT’s current matrix for your system before assuming coverage.
  • Skids during qualification. Code changes fast during commissioning and qualification. Bring the vendor’s skid code under control before the first protocol is executed, not after.
  • Vendor validation packages. Some skid suppliers deliver their own validation documents. Bringing the skid under plant-side backup and compare should not invalidate that package, so write the requirement into the user requirement specification before the purchase order.
  • Restore is a GMP event too. Loading the approved version after a failure still needs verification and a record before the equipment returns to production. Rehearse it once, on a non-critical system, so the first real restore is not also the first time anyone reads the SOP.
  • Alert handling. A compare difference is a potential deviation. Without a defined triage route, sites either drown in alerts or stop reading them.

An owner’s representative who understands both the quality system and the automation layer shortens most of these; see owner’s engineer and our guide to quality, MES and traceability. For a sector where speed of change rather than validation drives the case, compare octoplant in food and beverage.


Related: octoplant use cases by industry · Audit Trail and 21 CFR Part 11 · Food and Beverage · AMDT hub

Frequently asked questions

Is octoplant GMP compliant?

No software is GMP compliant on its own. Compliance belongs to the regulated company's processes, and a tool supports them. octoplant provides version history, compare and an audit trail that can serve as evidence in change control, and AMDT offers IQ/OQ services to help qualify the installation. Your validation team still writes the requirements and approves the result.

Does AMDT offer IQ/OQ for octoplant?

Yes. AMDT lists IQ/OQ Services among its service offerings, alongside implementation and update services. Installation and operational qualification documents help, but performance qualification against your own processes, and the decision that the system is fit for its intended use, remain with the plant. Ask what the IQ/OQ package covers and how it is updated with each release.

Was there a GxP edition of versiondog?

Yes, a versiondog GxP Edition existed before octoplant replaced versiondog. Whether octoplant has a direct equivalent edition is not confirmed in public sources as of October 2026; AMDT's published editions are Core, Plus and Premium, with Premium described for medium and large or highly regulated environments. Ask AMDT directly.

Which pharma companies use octoplant?

AMDT publishes a customer story on Humanwell, a pharmaceutical manufacturer. Its pharma industry page also shows logos of large drug makers, but logos are not case studies and do not tell you scope or results. Ask AMDT or a partner for a reference site with a similar validation approach to your own.

How does octoplant help with unauthorized changes in a validated plant?

Scheduled jobs upload programs from devices and compare them against the approved version. A difference that has no matching change record is a candidate deviation. The tool finds it within one job cycle rather than at the next periodic review or after a batch failure. Investigating and closing it is still a quality system task.

References and further reading

  1. 21 CFR Part 11 -- Electronic Records; Electronic Signatures · U.S. Government Publishing Office (eCFR)The regulation text: audit trails, system validation and controls for electronic records.
  2. Part 11, Electronic Records; Electronic Signatures - Scope and Application · U.S. Food and Drug AdministrationFDA's guidance on how it applies Part 11, including its risk-based approach to audit trails and validation.
  3. EudraLex Volume 4, Annex 11: Computerised Systems · European CommissionThe EU GMP expectations for validation, change and configuration management, and backup of computerised systems.
  4. GAMP 5 Guide 2nd Edition · ISPEThe risk-based framework most sites use to categorise and validate a tool like this one.
  5. Pharma · AMDTAMDT's pharma positioning and the frameworks it says it addresses.
  6. Reliable OT Data at Humanwell Pharmaceutical. · AMDT
  7. Pricing · AMDT (octoplant.com)

← Industries

Have a project that needs technical ownership?

Send us the situation. If it is not something we should take on, we will say so.